In April 2023, a curious law professor and lawyer submitted his “Introductory Civil Procedure” exam to ChatGPT, an AI chatbot, to see how it would score. The results were surprising: ChatGPT outperformed over 70% of his…
more
/ Civil Procedure, Law Practice Products & Services, Intellectual Property, Science, Computers, & Technology
Businesses can prevent third parties from misusing their valuable and commercially sensitive business information and trade secrets through contracts and the common law in Canada…
more
/ Business Organizations, Commercial Law & Contracts, Intellectual Property
Explore skinny labelling & obviousness in Canada and Australia -
If you are an intellectual property (IP) owner, a litigator or an in-house legal professional managing IP litigation in multiple jurisdictions, don’t miss this…
more
/ Health, Intellectual Property, International Law & Trade, Science, Computers, & Technology
Explore skinny labelling & obviousness in Canada and Australia -
If you are an intellectual property (IP) owner, a litigator or an in-house legal professional managing IP litigation in multiple jurisdictions, don’t miss this…
more
/ Health, Intellectual Property, International Law & Trade, Science, Computers, & Technology
In a public decision dated August 8, 2024, Justice Furlanetto of the Federal Court found Boehringer Ingelheim’s Canadian Patent No. 2,591,083 (the 083 patent) valid and infringed by JAMP in an action under the Patented Medicines…
more
/ Health, Intellectual Property
Formally known as prohibited marks, official marks are a distinctive feature of Canadian trademark law, providing government entities with an exclusive and powerful tool to protect their marks, symbols and emblems. Private…
more
/ Intellectual Property
The College of Patent Agents & Trademark Agents (CPATA) recently issued an alert regarding a surge in fraudulent emails targeting trademark owners. As is typical of these “phishing” scams, the emails often pressure recipients to…
more
/ Business Organizations, Consumer Protection, Intellectual Property
Manitoba has implemented a Biosimilars Initiative effective August 1, 2024. Manitoba is the last province in Canada to implement a biosimilar policy that requires patients receiving funding under the Manitoba Pharmacare program…
more
/ Health, Insurance
Registering a trademark across multiple jurisdictions can be a complex process. Brand owners must strike a balance between maximizing protection across their jurisdictions of interest and managing both risks and costs to develop…
more
/ Business Organizations, Intellectual Property, International Law & Trade
In Rogers Media Inc et al v John Doe 1 et al, 2024 FC 1082, the Federal Court (Canada) (the Court) issued the first site-blocking judgment allowing the applicants to simultaneously protect live content in multiple sports leagues…
more
/ Art, Entertainment, & Sports Law, Communications & Media Law, Intellectual Property
On June 25, 2024, Health Canada published a notice of intent and Building resilience: Health Canada’s plan to address health product shortages, 2024 to 2028, relating to Health Canada’s plan over the next 4 years to address…
more
/ Administrative Law, Health, Products Liability
As previously reported, the Patented Medicine Prices Review Board (PMPRB) published a Discussion Guide for Phase 2 Consultations on New Guidelines as part of a three-phase consultation process that started in September 2023…
more
/ Administrative Law, Health, Intellectual Property
Last year, we discussed the ever-increasing interest in green branding and how marketing claims related to the environment are receiving increased scrutiny by Canadian regulatory authorities. It should therefore come as no…
more
/ Administrative Law, Commercial Law & Contracts, Consumer Protection, Environmental Law
In the first half of 2024, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. The Rx IP Update team at Smart & Biggar has collected the top stories from January to June and…
more
/ Health, Intellectual Property, Science, Computers, & Technology
As previously reported, the Federal Court of Appeal dismissed two decisions relating to paliperidone palmitate (Janssen’s INVEGA SUSTENNA), finding in a summary trial that each of Pharmascience and Apotex would induce…
more
/ Civil Procedure, Health, Intellectual Property
